Amir Weiss Teva Pharmaceutical Industries LTD (TEVA) insider trading activity

Amir Weiss is Chief Accounting Officer of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 5,650 shares of TEVA, which is worth approximately $143,566. The most recent transaction as insider was on Dec 16, 2025, when has been sold 12,300 shares (Ordinary Shares) at a price of $30.2 per share, resulting in proceeds of $371,460. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.65K

81.32% 3M change

9.09% 12M change

Total Value Held $143,566

Amir Weiss Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2025	SELL Open market or private sale	$371,460 $30.2 p/Share	12,300 Reduced 68.52%	5,650 Ordinary Shares
Nov 06 2025	SELL Open market or private sale	$300,612 $24.44 p/Share	12,300 Reduced 40.66%	17,950 Ordinary Shares
Mar 05 2025	BUY Exercise of conversion of derivative security	-	3,566 Added 10.55%	30,250 Ordinary Shares
Mar 04 2025	BUY Exercise of conversion of derivative security	-	16,326 Added 37.96%	26,684 Ordinary Shares
Mar 03 2025	BUY Exercise of conversion of derivative security	-	5,179 Added 33.33%	10,358 Ordinary Shares
May 16 2024	SELL Open market or private sale	$210,372 $16.65 p/Share	12,635 Reduced 70.93%	5,179 Ordinary Shares
May 15 2024	SELL Open market or private sale	$260,400 $16.8 p/Share	15,500 Reduced 46.53%	17,814 Ordinary Shares

Mar 05 2024	BUY Exercise of conversion of derivative security	-	3,564 Added 9.66%	33,314 Ordinary Shares
Mar 04 2024	BUY Exercise of conversion of derivative security	-	10,676 Added 26.41%	29,750 Ordinary Shares
Mar 03 2024	BUY Exercise of conversion of derivative security	-	5,179 Added 21.35%	19,074 Ordinary Shares
Feb 28 2024	BUY Exercise of conversion of derivative security	-	3,219 Added 18.81%	13,895 Ordinary Shares
Feb 01 2024	SELL Open market or private sale	$392,945 $12.37 p/Share	31,766 Reduced 74.85%	10,676 Ordinary Shares
Aug 04 2023	SELL Open market or private sale	$19,651 $9.92 p/Share	1,981 Reduced 4.46%	42,442 Ordinary Shares
Mar 05 2023	BUY Exercise of conversion of derivative security	-	3,564 Added 7.96%	41,204 Ordinary Shares
Mar 04 2023	BUY Exercise of conversion of derivative security	-	13,082 Added 25.79%	37,640 Ordinary Shares
Feb 28 2023	BUY Exercise of conversion of derivative security	-	3,219 Added 10.39%	27,777 Ordinary Shares
Mar 05 2022	BUY Exercise of conversion of derivative security	-	3,564 Added 12.67%	24,558 Ordinary Shares
Mar 04 2022	BUY Exercise of conversion of derivative security	-	2,403 Added 10.27%	20,994 Ordinary Shares
Mar 02 2022	BUY Exercise of conversion of derivative security	-	981 Added 5.01%	18,591 Ordinary Shares
Feb 28 2022	BUY Exercise of conversion of derivative security	-	3,219 Added 15.45%	17,610 Ordinary Shares

Amir Weiss

Chief Accounting Officer

Tel Aviv, L3

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if

Value

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Track Activities on TEVA

Account